Table 1.
Baseline characteristics of the studied cohort and univariate analysis for cardiac complications.
| All (N=174) | Cardiac complications (N=14) | No cardiac complications (N=160) | p-value | |
|---|---|---|---|---|
| Age | 79 (66–84) | 80 (67–83) | 79 (66–84) | 0.342 |
| Gender (male) | 95 (54.6%) | 7 (50%) | 88 (55.3%) | 0.700 |
| Arterial hypertension | 123 (70.7%) | 9 (64.3%) | 114 (71.3%) | 0.557 |
| Diabetes mellitus | 43 (24.7%) | 5 (35.7%) | 38 (23.9%) | 0.341 |
| Dyslipidemiaa | 83 (47.7%) | 5 (35.7%) | 78 (49.4%) | 0.339 |
| Previous stroke | 35 (20.1%) | 4 (28.6%) | 31 (19.5%) | 0.486 |
| Previous disability | 27 (15.5%) | 4 (28.6%) | 23 (14.5%) | 0.239 |
| Atrial fibrillationa | 49 (28.2%) | 5 (35.7%) | 44 (29.1%) | 0.760 |
| CADa | 27 (15.6%) | 3 (21.4%) | 24 (15.2%) | 0.464 |
| Previous congestive heart failure | 15 (8.6%) | 1 (7.1%) | 14 (8.8%) | 0.999 |
| OCSPa | ||||
| TACI | 54 (35.3%) | 11 (78.6%) | 43 (30.9%) | 0.005 |
| PACI | 66 (43.1%) | 3 (21.4%) | 63 (45.3%) | |
| POCI | 16 (10.5%) | 0 (0%) | 16 (11.5%) | |
| LACI | 17 (11.1%) | 0 (0%) | 17 (12.2%) | |
| TOASTa | ||||
| LAA | 30 (17.3%) | 6 (42.9%) | 24 (15.1%) | 0.071 |
| CE | 73 (42.2%) | 6 (42.9%) | 67 (42.1%) | |
| LAC | 18 (10.4%) | 0 (0%) | 18 (11.3%) | |
| UND | 47 (27.1%) | 2 (14.3%) | 45 (28.3%) | |
| Laterality (right)a | 78 (44.8%) | 5 (41.7%) | 31 (39.2%) | 0.999 |
| Baseline NIHSS | 7.5 (3–12.5) | 12 (7–17) | 7 (3–12) | 0.001 |
| SBP (mmHg) | 150.1 ± 16.2 | 131.7 ± 27 | 150.3 ± 31.4 | 0.148 |
| DBP (mmHg) | 78.5 (70–86.5) | 61.5 (54–75) | 79 (70–87) | 0.018 |
| Glycemia (mg/dl) | 122.5 (106–152) | 139 (129–189) | 121 (106–152) | 0.979 |
| Creatinine (mg/dl) | 0.96 (0.78–1.16) | 0.97 (0.82–1.12) | 0.95 (0.77–1.18) | 0.863 |
| Elevated hs-TnI | 39 (22%) | 8 (57.1%) | 31 (19.5%) | 0.004 |
| Poor outcomea | 73/151 (48.3%) | 13/14 (92.9%) | 60/137 (43.8%) | 0.001 |
| Mortalitya | 28/151 (18.5%) | 9/14 (64.3%) | 19/137 (13.9%) | <0.0001 |
CAD: coronary artery disease; CE: cardioembolic; DBP: diastolic blood pressure; hs-TnI: ultrasensitive Troponin I; LAA: large artery atherothrombotic; LAC: lacunar; LACI: lacunar infarct; NIHSS: National Institutes of Health Stroke Scale; OCSP: Oxfordshire Stroke Project classification; PACI: partial anterior circulation infarct; POCI: posterior arterial circulation infarct; SBP: systolic blood pressure; TACI: total anterior circulation infarct; TOAST: Trial of Org 10172 in Acute Stroke Treatment; UND: undetermined.
Data are expressed as N (%), median (interquartile range), or mean ± standard deviation.
a
denotes existence of missing values.